PortalPublikationenInhibition of intestinal absorption and decorporation of rad...

Inhibition of intestinal absorption and decorporation of radiocaesium in humans by hexacyanoferrates(II).

Standard

Inhibition of intestinal absorption and decorporation of radiocaesium in humans by hexacyanoferrates(II). / Nielsen, Peter; Dresow, B; Fischer, R; Heinrich, H C.

in: Int J Rad Appl Instrum B, Jahrgang 18, Nr. 7, 7, 1991, S. 821-826.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Nielsen, P, Dresow, B, Fischer, R & Heinrich, HC 1991, 'Inhibition of intestinal absorption and decorporation of radiocaesium in humans by hexacyanoferrates(II).', Int J Rad Appl Instrum B, Jg. 18, Nr. 7, 7, S. 821-826. <http://www.ncbi.nlm.nih.gov/pubmed/1787095?dopt=Citation>

APA

Nielsen, P., Dresow, B., Fischer, R., & Heinrich, H. C. (1991). Inhibition of intestinal absorption and decorporation of radiocaesium in humans by hexacyanoferrates(II). Int J Rad Appl Instrum B, 18(7), 821-826. [7]. http://www.ncbi.nlm.nih.gov/pubmed/1787095?dopt=Citation

Vancouver

Nielsen P, Dresow B, Fischer R, Heinrich HC. Inhibition of intestinal absorption and decorporation of radiocaesium in humans by hexacyanoferrates(II). Int J Rad Appl Instrum B. 1991;18(7):821-826. 7.

Bibtex

@article{d7b348474f7d4ad48801c3a6dc30cacd,
title = "Inhibition of intestinal absorption and decorporation of radiocaesium in humans by hexacyanoferrates(II).",
abstract = "The effect of hexacyanoferrate(II) preparations, KFe[Fe(CN)6], (KFeHCF) anol Fe4[Fe(CN)6]3, (FeHCF) on intestinal radiocaesium absorption was studied in two male volunteers. The 134Cs absorption was decreased from 100 to 3-10% when 500-1000 mg KFeHCF or FeHCF were administered 10 min before the 134Cs-labelled test meal. However, when HCF was administered simultaneously with the test meal, the 134Cs absorption was decreased to only 38-63%. The biological half-time of previously absorbed 134Cs was reduced from 106 (73) to 44 (46) days by daily administration of 3 times 0.5 g KFeHCF. The 134Cs dose conversion factors lie below the values recommended by IRCP 30, indicating that the IRCP model represents a cautious description of the Cs biokinetics in our study.",
author = "Peter Nielsen and B Dresow and R Fischer and Heinrich, {H C}",
year = "1991",
language = "Deutsch",
volume = "18",
pages = "821--826",
number = "7",

}

RIS

TY - JOUR

T1 - Inhibition of intestinal absorption and decorporation of radiocaesium in humans by hexacyanoferrates(II).

AU - Nielsen, Peter

AU - Dresow, B

AU - Fischer, R

AU - Heinrich, H C

PY - 1991

Y1 - 1991

N2 - The effect of hexacyanoferrate(II) preparations, KFe[Fe(CN)6], (KFeHCF) anol Fe4[Fe(CN)6]3, (FeHCF) on intestinal radiocaesium absorption was studied in two male volunteers. The 134Cs absorption was decreased from 100 to 3-10% when 500-1000 mg KFeHCF or FeHCF were administered 10 min before the 134Cs-labelled test meal. However, when HCF was administered simultaneously with the test meal, the 134Cs absorption was decreased to only 38-63%. The biological half-time of previously absorbed 134Cs was reduced from 106 (73) to 44 (46) days by daily administration of 3 times 0.5 g KFeHCF. The 134Cs dose conversion factors lie below the values recommended by IRCP 30, indicating that the IRCP model represents a cautious description of the Cs biokinetics in our study.

AB - The effect of hexacyanoferrate(II) preparations, KFe[Fe(CN)6], (KFeHCF) anol Fe4[Fe(CN)6]3, (FeHCF) on intestinal radiocaesium absorption was studied in two male volunteers. The 134Cs absorption was decreased from 100 to 3-10% when 500-1000 mg KFeHCF or FeHCF were administered 10 min before the 134Cs-labelled test meal. However, when HCF was administered simultaneously with the test meal, the 134Cs absorption was decreased to only 38-63%. The biological half-time of previously absorbed 134Cs was reduced from 106 (73) to 44 (46) days by daily administration of 3 times 0.5 g KFeHCF. The 134Cs dose conversion factors lie below the values recommended by IRCP 30, indicating that the IRCP model represents a cautious description of the Cs biokinetics in our study.

M3 - SCORING: Zeitschriftenaufsatz

VL - 18

SP - 821

EP - 826

IS - 7

M1 - 7

ER -